版本:
中国

BRIEF-Mabvax Therapeutics enrolls patients in expansion of Phase I clinical trial for pancreatic cancer patients

Nov 28 Mabvax Therapeutics Holdings Inc

* Mabvax Therapeutics enrolls first patients in expansion of Phase I clinical trial treating newly diagnosed pancreatic cancer patients

* Mabvax Therapeutics Holdings says to present results from both dose expansion portions of monotherapy and combination with chemotherapy trials mid-year 2017 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐